| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.006 | 9.673 | 16.916 | 14.127 | 11.998 | 13.365 | 18.365 | 18.615 | 18.950 | 15.592 |
| Total Income - EUR | 13.006 | 9.673 | 16.916 | 14.127 | 11.998 | 13.365 | 18.365 | 18.615 | 18.950 | 15.592 |
| Total Expenses - EUR | 11.014 | 8.669 | 13.567 | 11.982 | 10.691 | 13.912 | 14.698 | 15.965 | 17.520 | 17.011 |
| Gross Profit/Loss - EUR | 1.992 | 1.004 | 3.349 | 2.146 | 1.307 | -547 | 3.668 | 2.650 | 1.429 | -1.419 |
| Net Profit/Loss - EUR | 1.602 | 714 | 2.841 | 1.722 | 947 | -954 | 3.117 | 2.091 | 1.205 | -1.419 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dermadjetic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 103 | 95 | 86 | 80 | 74 | 67 |
| Current Assets | 14.586 | 15.049 | 21.190 | 24.165 | 24.064 | 17.239 | 15.150 | 17.002 | 12.759 | 11.294 |
| Inventories | 14.586 | 15.049 | 21.190 | 22.167 | 22.201 | 16.089 | 12.326 | 7.836 | 2.602 | 3.426 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 29 |
| Cash | 0 | 0 | 0 | 1.997 | 1.863 | 1.150 | 2.824 | 9.166 | 10.155 | 7.839 |
| Shareholders Funds | 6.915 | 7.559 | 10.272 | 11.805 | 12.524 | 11.332 | 14.198 | 16.333 | 11.627 | 10.142 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.671 | 7.491 | 10.918 | 12.359 | 11.643 | 6.002 | 1.038 | 749 | 1.206 | 1.219 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4789 - 4789" | |||||||||
| CAEN Financial Year |
4789
|
|||||||||
Comments - Dermadjetic S.r.l.